OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK
Yaling Yang, Lucy Abel, James Buchanan, et al.
PharmacoEconomics - Open (2018) Vol. 3, Iss. 3, pp. 281-291
Open Access | Times Cited: 22

Showing 22 citing articles:

Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, et al.
PharmacoEconomics (2021) Vol. 39, Iss. 7, pp. 771-788
Open Access | Times Cited: 32

The health technology assessment approach of the economic value of diagnostic tests: a literature review
David Bardey, Philippe De Donder, Vera Zaporozhets
Discover Health Systems (2025) Vol. 4, Iss. 1
Open Access

Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations
Bethany Shinkins, A. Joy Allen, James Karichu, et al.
Applied Health Economics and Health Policy (2024) Vol. 22, Iss. 2, pp. 131-144
Open Access | Times Cited: 2

MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis
Alexis Llewellyn, Thai Han Phung, Marta Soares, et al.
Health Technology Assessment (2024), pp. 1-310
Open Access | Times Cited: 2

Through the quality kaleidoscope: reflections on research in dentomaxillofacial imaging
Madeleine Rohlin, Keith Horner, Christina Lindh, et al.
Dentomaxillofacial Radiology (2020) Vol. 49, Iss. 6, pp. 20190484-20190484
Open Access | Times Cited: 16

Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
Edna Keeney, Howard Thom, Emma L. Turner, et al.
PharmacoEconomics (2021) Vol. 39, Iss. 5, pp. 589-600
Open Access | Times Cited: 15

Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges
Wenjia Chen, Yi Wang, Yaroslava Zemlyanska, et al.
Value in Health (2023) Vol. 26, Iss. 9, pp. 1425-1434
Closed Access | Times Cited: 5

Health Economic Decision Tree Models of Diagnostics for Dummies: A Pictorial Primer
Tamlyn Rautenberg, Annette Gerritsen, Martin Downes
Diagnostics (2020) Vol. 10, Iss. 3, pp. 158-158
Open Access | Times Cited: 13

Setting analytical performance specifications using HbA1c as a model measurand
Tze Ping Loh, Alison Smith, Katy Bell, et al.
Clinica Chimica Acta (2021) Vol. 523, pp. 407-414
Open Access | Times Cited: 11

Understanding innovation of health technology assessment methods: the IHTAM framework
Li Jiu, Milou A. Hogervorst, Rick A. Vreman, et al.
International Journal of Technology Assessment in Health Care (2022) Vol. 38, Iss. 1
Open Access | Times Cited: 7

EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation
Ana Duarte, Mark Corbett, Hollie Melton, et al.
Health Technology Assessment (2022) Vol. 26, Iss. 49, pp. 1-184
Open Access | Times Cited: 7

Barriers, enablers, benefits, and drawbacks to point-of-care testing: a survey of the general practice out-of-hours service in Scotland
Sarah EE Mills, SM Babar Akbar, Virginia Hernandez Santiago
BJGP Open (2023) Vol. 8, Iss. 2, pp. BJGPO.2023.0094-BJGPO.2023.0094
Open Access | Times Cited: 3

Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review
Martin Vu, Koen Degeling, Ella R. Thompson, et al.
European Journal Of Haematology (2022) Vol. 108, Iss. 6, pp. 469-485
Open Access | Times Cited: 5

The clinical performance and cost-effectiveness of two psychosocial assessment models in maternity care: The Perinatal Integrated Psychosocial Assessment study
Georgina M. Chambers, Willings Botha, Nicole Reilly, et al.
Women and Birth (2021) Vol. 35, Iss. 2, pp. e133-e141
Open Access | Times Cited: 7

The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing
Thomas Fanshawe, Philip J. Turner, Marjorie Gillespie, et al.
Diagnostic and Prognostic Research (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 4

Implementation of medical tests in a Value-Based healthcare environment: A framework for delivering value
Andrew St John, Maurice O’Kane, Robert H. Christenson, et al.
Clinica Chimica Acta (2021) Vol. 521, pp. 90-96
Closed Access | Times Cited: 5

Who Conducts Health Economic Evaluations of Laboratory Tests? A Scoping Review
Isabella Giusepi, Andrew St John, Paul Jülicher
The Journal of Applied Laboratory Medicine (2020) Vol. 5, Iss. 5, pp. 954-966
Open Access | Times Cited: 4

Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review
Sean Docking, Lan Gao, Zanfina Ademi, et al.
Applied Health Economics and Health Policy (2023) Vol. 21, Iss. 3, pp. 467-475
Open Access

Economic evaluation of genome-guided treatment in oncology
Paula Lorgelly
Elsevier eBooks (2023), pp. 33-45
Closed Access

Evaluating the Quality of the Economic Evidence in Colorectal Cancer Genomics Studies
Vivek S. Chaudhari, Kanchan C Hole, Amalia M. Issa
Personalized Medicine (2022) Vol. 19, Iss. 4, pp. 361-375
Closed Access

Page 1

Scroll to top